Correlation Between Genscript Biotech and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Genscript Biotech and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genscript Biotech and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genscript Biotech and Keros Therapeutics, you can compare the effects of market volatilities on Genscript Biotech and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genscript Biotech with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genscript Biotech and Keros Therapeutics.
Diversification Opportunities for Genscript Biotech and Keros Therapeutics
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Genscript and Keros is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Genscript Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genscript Biotech are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Genscript Biotech i.e., Genscript Biotech and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Genscript Biotech and Keros Therapeutics
Assuming the 90 days horizon Genscript Biotech is expected to generate 0.99 times more return on investment than Keros Therapeutics. However, Genscript Biotech is 1.01 times less risky than Keros Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Keros Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 140.00 in Genscript Biotech on August 29, 2024 and sell it today you would lose (3.00) from holding Genscript Biotech or give up 2.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Genscript Biotech vs. Keros Therapeutics
Performance |
| Timeline |
| Genscript Biotech |
| Keros Therapeutics |
Genscript Biotech and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genscript Biotech and Keros Therapeutics
The main advantage of trading using opposite Genscript Biotech and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genscript Biotech position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. Zentalis Pharmaceuticals Llc | Genscript Biotech vs. Innovent Biologics |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |